
The Women's Health Initiative finding that taking estrogen plus a progestin for more than five years increased the risk of cardiovascular disease and breast cancer left the safety of using estrogen to treat hot flashes open to question. How low a dose and how short a duration would be safe and effective are unknown. Lifestyle changes, antidepressants, alpha-2 agonists, anticonvulsants, phytoestrogens and other dietary supplements have been tried as alternatives to estrogen, with mixed results.
Vasomotor System, Cimicifuga, Dose-Response Relationship, Drug, Hot Flashes, Humans, Estrogens, Female, Nonprescription Drugs, Menopause, Progestins, Phytotherapy, Randomized Controlled Trials as Topic
Vasomotor System, Cimicifuga, Dose-Response Relationship, Drug, Hot Flashes, Humans, Estrogens, Female, Nonprescription Drugs, Menopause, Progestins, Phytotherapy, Randomized Controlled Trials as Topic
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
